Novo’s Weekly Insulin Denied Approval as FDA Seeks Details
<-bsp-bb-link state="{"bbHref":"bbg://securities/NOVOB%20DC%20Equity/MODL","_id":"00000190-a10e-d6e5-adde-bbdf7f870000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Novo Nordisk A/S’s once-weekly insulin failed to get approval from US regulators Wednesday after the government asked for more information in order to complete its review.